Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Acquisitions (2022)

Innoviva filings provide 1 years of Acquisitions readings, the most recent being $23.1 million for Q3 2022.

  • On a quarterly basis, Acquisitions changed N/A to $23.1 million in Q3 2022 year-over-year; TTM through Sep 2023 was $23.1 million, a 50.0% decrease, with the full-year FY2022 number at $23.1 million, changed N/A from a year prior.
  • Acquisitions hit $23.1 million in Q3 2022 for Innoviva, roughly flat from $23.1 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $23.1 million in Q1 2022 to a low of $23.1 million in Q1 2022.